Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2023-06-05 00:00:00 ET · period of report 2021-06-22 · accession 0001209191-23-034695 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-05 | 2021-06-22+ | ACAD | Daly James M | Dir | M - OptEx | — | +18.0K | 9,450 | New | — |
| DM | 2023-06-05 | 2023-06-01 | ACAD | Daly James M | Dir | A - Grant | $0.00 | +17.7K | 11.0K | New | $0 |
| DM | 2023-06-05 | 2021-06-22+ | ACAD | Daly James M | Dir | M - OptEx | $0.00 | -18.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-22 | M | A | 3,059 | — | 3,059 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Acadia common stock. |
| 2 | Common | Common Stock | 2023-06-01 | M | A | 8,552 | — | 18,002 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Acadia common stock. |
| 3 | Common | Common Stock | 2022-06-07 | M | A | 6,391 | — | 9,450 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Acadia common stock. |
| 4 | Derivative | Restricted Stock Units | 2023-06-01 | A | A | 6,652 | $0.00 | 6,652 | D | — · — to — | 6,652 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Acadia common stock. (F2) The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date. |
| 5 | Derivative | Director Stock Options (Right to Buy) | 2023-06-01 | A | A | 11,045 | $0.00 | 11,045 | D | $23.90 · — to 2033-05-31 | 11,045 Common Stock | (F3) The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date. |
| 6 | Derivative | Restricted Stock Units | 2023-06-01 | M | D | 8,552 | $0.00 | 0 | D | — · — to — | 8,552 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Acadia common stock. (F2) The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date. |
| 7 | Derivative | Restricted Stock Units | 2022-06-07 | M | D | 6,391 | $0.00 | 0 | D | — · — to — | 6,391 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Acadia common stock. (F2) The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date. |
| 8 | Derivative | Restricted Stock Units | 2021-06-22 | M | D | 3,059 | $0.00 | 0 | D | — · — to — | 3,059 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Acadia common stock. (F2) The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date. |